---
figid: PMC3281723__zbc0041294990002
figlink: /pmc/articles/PMC3281723/figure/F2/
number: FIGURE 2
caption: 'Role of PHLPP in terminating oncogenic signaling pathways. PHLPP (red) directly
  dephosphorylates and inactivates Akt, PKC, and S6K, thus opposing cell survival
  and proliferation signals, and directly dephosphorylates and activates Mst1, thus
  promoting pro-apoptotic signals. Indicated are two negative feedback loops: high
  Akt activity up-regulates PHLPP levels by suppressing GSK-3-dependent degradation,
  and high S6K activity up-regulates PHLPP expression. Note that targeting the PI3K
  pathway within these feedback loops will have the consequence of decreasing PHLPP
  levels, thus promoting prosurvival pathways mediated by PKC and inhibiting pro-apoptotic
  pathways mediated by Mst1. Protein kinases are shown in green, and tumor suppressors
  are shown in red (the lipid phosphatase PTEN, which opposes the lipid kinase PI3K,
  and the protein phosphatase PHLPP, which controls the indicated protein kinases).
  RTK, receptor tyrosine kinase.'
pmcid: PMC3281723
papertitle: 'Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase (PHLPP):
  A New Player in Cell Signaling.'
reftext: Noel A. Warfel, et al. J Biol Chem. 2012 Feb 3;287(6):3610-3616.
pmc_ranked_result_index: '97890'
pathway_score: 0.9484716
filename: zbc0041294990002.jpg
figtitle: Role of PHLPP in terminating oncogenic signaling pathways
year: '2012'
organisms: Homo sapiens
ndex: 8997531f-def9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3281723__zbc0041294990002.html
  '@type': Dataset
  description: 'Role of PHLPP in terminating oncogenic signaling pathways. PHLPP (red)
    directly dephosphorylates and inactivates Akt, PKC, and S6K, thus opposing cell
    survival and proliferation signals, and directly dephosphorylates and activates
    Mst1, thus promoting pro-apoptotic signals. Indicated are two negative feedback
    loops: high Akt activity up-regulates PHLPP levels by suppressing GSK-3-dependent
    degradation, and high S6K activity up-regulates PHLPP expression. Note that targeting
    the PI3K pathway within these feedback loops will have the consequence of decreasing
    PHLPP levels, thus promoting prosurvival pathways mediated by PKC and inhibiting
    pro-apoptotic pathways mediated by Mst1. Protein kinases are shown in green, and
    tumor suppressors are shown in red (the lipid phosphatase PTEN, which opposes
    the lipid kinase PI3K, and the protein phosphatase PHLPP, which controls the indicated
    protein kinases). RTK, receptor tyrosine kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKCI
  - PIK3CA
  - PRKCE
  - PIK3CB
  - PIK3R3
  - PIK3R4
  - PRKCH
  - MST1
  - PIK3R5
  - PRKCG
  - PIK3R6
  - PIK3CG
  - PRKCQ
  - AKT3
  - PRKCD
  - PRKCB
  - PRKCZ
  - PHLPP1
  - MTOR
  - PRKD3
  - GSK3B
  - PIK3CD
  - AKT2
  - GSK3A
  - PRKCA
  - AKT1
  - PTEN
  - Cancer
genes:
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: Mst1
  symbol: MST1
  source: hgnc_symbol
  hgnc_symbol: MST1
  entrez: '4485'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PHLPP
  symbol: PHLPP
  source: hgnc_prev_symbol
  hgnc_symbol: PHLPP1
  entrez: '23239'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
